Life ScienceCompany
Trans-Hit Biomarkers Ownership
Who owns Trans-Hit Biomarkers?
Trans-Hit Biomarkers is owned by Azenta. It was acquired on December 3, 2020.
Trans-Hit Biomarkers Business Overview
Where is Trans-Hit Biomarkers headquartered?
Trans-Hit Biomarkers is headquartered in Laval, Quebec.
What sector is Trans-Hit Biomarkers in?
Trans-Hit Biomarkers is a life science company.
Life Science M&A Summary in 2020
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.
Join Mergr to view all 290 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 267 by strategics.